Trials / Completed
CompletedNCT01241474
Effect of Fish Oil on Insulin Sensitivity
Chronic Long-chain n-3 PUFA Supplement and Insulin Action in Human Subjects With Impaired Glucose Regulation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- University of Aberdeen · Academic / Other
- Sex
- All
- Age
- 40 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a prolonged (9 month) high (6g/d) of marine oil improves insulin sensitivity and glucose control in subjects with impaired glucose regulation.
Detailed description
The incidence of Type 2 diabetes is related both to age and obesity. The disease impacts on quality of life and treatments represent a major health cost. Prevention or delayed onset of the disease remains a key target. Animal studies have shown that provision of high amounts of fish oil in the diet improves insulin sensitivity but human trials have proved equivocal. Recent dose-response trials in animals have shown the improved insulin sensitivity only occurs when the proportion of n-3 long chain polyunsaturated fatty acids (n-3 PUFA), docosahexaenoic acid and eicosapentaenoic acid, exceeds 14% of the total phospholipid fraction within tissue cell membranes. To achieve such values in humans would require a high dose of n-3 PUFA supplied over a prolonged period of time. This is tested within the current study where a daily dose of 6 g day of fish oil (containing a total of 3g docosahexaenoic acid plus eicosapentaenoic acid) is supplied for 9 months. As well as improving control of glycemia increased insulin sensitivity may also enhance protein metabolism and reduce the impact of frailty in older subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | EPAX 6000 (marine omega 3 EPA/DHA fatty acid concentrates | 6 x 1g capsules per day of marine oil (contains 3g/d docosahexaenoic acid plus eicosapentaenoic acid) for a 9 month period |
| DIETARY_SUPPLEMENT | Maize (corn) oil | 6 x 1g capsules per day for 9 months |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2010-11-16
- Last updated
- 2012-08-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01241474. Inclusion in this directory is not an endorsement.